Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
07.05. | BPC Instruments AB: BPC Instruments Annual Report for 2024 | 566 | PR Newswire | LUND, Sweden, May 7, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the Annual Report for the year 2024. The Annual Report is available as an attached file to this release and... ► Artikel lesen | |
07.05. | BPC Instruments AB: BPC Instruments reports results for Q1 2025 | 314 | PR Newswire | LUND, Sweden, May 7, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the interim report for the period January 1 - March 31, 2025. The interim report is available as an attachment... ► Artikel lesen | |
24.04. | Notice of Annual General Meeting in BPC Instruments AB (publ) | 1 | Cision News | ||
10.04. | BPC INSTRUMENTS AB: BPC Instruments appoints new CFO | 1 | Cision News | ||
26.02. | BPC Instruments AB: BPC Instruments reports result for year 2024 | 423 | PR Newswire | LUND, Sweden, Feb. 26, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the year-end report for the year 2024. The year-end report is available as an attached file to this release... ► Artikel lesen | |
26.02. | BPC Instruments AB: BPC Instruments reports result for year 2024 | 219 | PR Newswire | LUND, Sweden, Feb. 26, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the year-end report for the year 2024. The year-end report is available as... ► Artikel lesen | |
20.02. | BPC Instruments AB: BPC Instruments receives order from DairyExperts for animal nutrition research | 372 | PR Newswire | LUND, Sweden, Feb. 20, 2025 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces an order of approx. SEK 0.5 million from DairyExperts, a US-based organisation specialising in livestock... ► Artikel lesen | |
12.02. | Bulletin from the Extraordinary General Meeting of BPC Instruments AB (publ) | 1 | Cision News | ||
BPC INSTRUMENTS Aktie jetzt für 0€ handeln | |||||
24.01. | BPC Instruments AB: BPC announces Directed Share Issue to Eiffel Investment Group | 493 | PR Newswire | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH... ► Artikel lesen | |
24.01. | Notice of Extraordinary General Meeting in BPC Instruments AB (publ) | 2 | Cision News | ||
08.01. | BPC INSTRUMENTS AB: BPC Instruments expands to new facility in Lund | 1 | Cision News | ||
08.01. | WIHLBORGS FASTIGHETER AB: New build by Wihlborgs for BPC Instruments in Lund | 5 | Cision News | ||
20.12.24 | BPC Instruments AB: Berenberg acquires shares in BPC | 603 | PR Newswire | LUND, Sweden, Dec. 20, 2024 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces that the Berenberg European Micro Cap Fund has acquired 4.8 percent of outstanding shares in BPC via... ► Artikel lesen | |
12.12.24 | BPC Instruments AB: BPC Instruments receives orders of 1,1 MSEK for newly launched BPC Air | 695 | PR Newswire |
LUND, Sweden, Dec. 12, 2024 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") is pleased to announce orders from KTH Sweden and University of Texas USA, totaling 1,1 MSEK. These orders include... ► Artikel lesen | |
05.12.24 | BPC INSTRUMENTS AB: BPC Instruments receives orders from US bioenergy firm valued at 1.1 MSEK | 1 | Cision News | ||
14.11.24 | BPC Instruments AB: BPC Instruments reports results for the period January - September 2024 | 1.029 | PR Newswire | LUND, Sweden, Nov. 14, 2024 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the interim report for the period January 1-September 30, 2024. The interim report is available as an attached... ► Artikel lesen | |
23.09.24 | BPC Instruments AB: BPC Instruments launches the BPC Titan - a new solution for gas flow and volume monitoring in pilot and small scales fermentation processes | 823 | PR Newswire | LUND, Sweden, Sept. 23, 2024 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces the global launch of its latest innovation, the BPC Titan, specifically designed for biological fermentation... ► Artikel lesen | |
28.08.24 | BPC Instruments AB: BPC Instruments reports results for H1 and Q2 2024 | 659 | PR Newswire | LUND, Sweden, Aug. 28, 2024 /PRNewswire/ -- BPC Instruments ("BPC" or "the Company") hereby publishes the half-year report for the period January 1-June 30, 2024. The half-year report is... ► Artikel lesen | |
26.08.24 | BPC Instruments AB: BPC secures additional orders from a multinational oil and gas company for biogas production | 1.308 | PR Newswire | LUND, Sweden, Aug. 26, 2024 /PRNewswire/ -- BPC Instruments AB ("BPC") is proud to announce the receipt of two consecutive purchase orders from the California-based branch of a prominent... ► Artikel lesen | |
17.07.24 | BPC Instruments AB: BPC secures order from Spanish Research Institute for enhanced anaerobic digestion research | 484 | PR Newswire | LUND, Sweden, July 17, 2024 /PRNewswire/ -- BPC Instruments AB ("BPC") has received a purchase order from a Spanish research institute to advance their anaerobic digestion research to meet... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
QIAGEN | 37,615 | +0,36 % | ANALYSE-FLASH: UBS belässt Qiagen auf 'Neutral' - Ziel 48 Dollar | ZÜRICH (dpa-AFX Broker) - Die Schweizer Großbank UBS hat Qiagen auf "Neutral" mit einem Kursziel von 48 US-Dollar belassen. Den hohen Margen im Geschäft mit Laborverbrauchsmaterialien stehe sein fehlendes... ► Artikel lesen | |
TEMPUS AI | 62,60 | 0,00 % | Tempus AI: Starkes Wachstum - Verluste steigen jedoch weiter an | CHICAGO, Illinois (IT-Times) - Das Diagnose-Technologie-Unternehmen Tempus AI hat seine Ergebnisse für das erste Quartal 2025 bekannt gegeben und ein rasantes Wachstum vorgelegt. Tempus AI - Aktie:... ► Artikel lesen | |
SPRINGWORKS THERAPEUTICS | 46,075 | 0,00 % | Laufende Fusionskontrollverfahren: Merck KGaA, Darmstadt; Erwerb sämtlicher Anteile an und der alleinigen Kontrolle über SpringWorks Therapeutics, Inc., Stamford, Connecticut, USA | Datum der Anmeldung:08.05.2025Aktenzeichen:B3-54/25Unternehmen:Merck KGaA, Darmstadt; Erwerb sämtlicher Anteile an und der alleinigen Kontrolle über SpringWorks Therapeutics, Inc., Stamford, Connecticut... ► Artikel lesen | |
EVOTEC | 6,976 | -1,22 % | Evotec-Aktie mit leichten Kursgewinnen (7,086 €) | Im Plus liegt derzeit das Wertpapier von Evotec . Zuletzt zahlten Investoren für das Wertpapier 7,09 Euro. Am deutschen Aktienmarkt hat sich heute die Evotec-Aktie zwischenzeitlich um 2,99 Prozent verteuert.... ► Artikel lesen | |
RECURSION PHARMACEUTICALS | 4,250 | 0,00 % | Recursion Pharmaceuticals Plunges 22% in May: How to Play the Stock | ||
BIONTECH | 82,80 | +0,36 % | Biotech Report: Evotec fest, Biontech leichter | (shareribs.com) Frankfurt / New York 09.05.2025 - Biotech-Aktien zeigten sich im deutschen Handel uneinheitlich. Evotec legten deutlich zu. Qiagen und Biontech gaben nach. Auch an der Wall Street verlor... ► Artikel lesen | |
SUMMIT THERAPEUTICS | 23,070 | 0,00 % | Summit Therapeutics Q1 2025 slides: Strong cash position supports advancing Ivonescimab pipeline | ||
MODERNA | 21,100 | -0,21 % | Leichter Wertverlust bei der Moderna-Aktie (21,7192 €) | Die Aktie von Moderna notiert am Mittwoch ein wenig leichter. Die Aktie kostete zuletzt 24,34 US-Dollar. An der Börse liegt der Anteilsschein von Moderna derzeit im Minus. Das Wertpapier verbilligte... ► Artikel lesen | |
SEPTERNA | 10,100 | 0,00 % | Novo und Septerna kooperieren bei oralen Adipositas-Medikamenten | DJ Novo und Septerna kooperieren bei oralen Adipositas-Medikamenten
Von Dominic Chopping
DOW JONES--Das dänische Pharmaunternehmen Novo Nordisk hat eine Kooperationsvereinbarung mit dem US-Biotechunternehmen... ► Artikel lesen | |
ARCUTIS BIOTHERAPEUTICS | 13,640 | +0,29 % | Arcutis Biotherapeutics, Inc.: New Consensus Statements on Impact of Genital Psoriasis on Patients from Genital Psoriasis Wellness Consortium Published in Journal of the European Academy of Dermatology and Venereology Clinical Practice | ||
ADMA BIOLOGICS | 19,200 | -1,39 % | ADMA Biologics, Inc.: ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update | 1Q 2025 Total Revenue of $114.8 Million (Adjusted Total Revenue(1) of $118.6 Million), a 40% YoY Increase 1Q 2025 GAAP Net Income of $26.9 Million, a 51% YoY Increase 1Q 2025 Adjusted EBITDA(2) of... ► Artikel lesen | |
ARCELLX | 58,40 | 0,00 % | Arcellx GAAP EPS of -$1.13, revenue of $8.1M | ||
AVIDITY BIOSCIENCES | 28,980 | +2,04 % | Avidity Biosciences stock price target cut to $68 by H.C. Wainwright | ||
JANUX THERAPEUTICS | 23,290 | 0,00 % | Leerink cuts Janux Therapeutics price target to $89, keeps Outperform | ||
TAYSHA GENE THERAPIES | 2,560 | +8,02 % | Baird maintains Outperform on Taysha stock, reiterates $7 target |